MSC2530818 is primarily utilized in biomedical research, particularly in the study of epigenetic regulation and gene expression. It functions as a selective inhibitor of certain proteins involved in chromatin modification, making it a valuable tool for understanding cellular processes and disease mechanisms. Researchers employ this compound to investigate its potential in modulating pathways associated with cancer, neurological disorders, and other conditions linked to epigenetic dysregulation. Its application extends to drug discovery, where it serves as a lead compound for developing targeted therapies aimed at restoring normal epigenetic function in diseased cells. Additionally, MSC2530818 is used in experimental models to assess its efficacy and safety, contributing to advancements in precision medicine.